Fake Product Detection Using Blockchain(Medicine)

Fake Product Detection Using Blockchain in Medicine aims to combat counterfeit drugs, a significant issue affecting global health and safety. The review explores how blockchain technology can enhance transparency, traceability, and security in the pharmaceutical supply chain, reducing the risk of fake medicines reaching consumers. Blockchain’s decentralized, immutable ledger enables real-time tracking of drugs from manufacturing to distribution, providing a transparent, verifiable record of each transaction. This ensures that every stakeholder in the supply chain, including manufacturers, wholesalers, and pharmacies, can authenticate a product’s origin and legitimacy. The review highlights the role of smart contracts, which automate verification processes and ensure compliance with regulatory standards. Key findings suggest that blockchain can drastically reduce counterfeiting by offering an auditable and tamper-proof system for verifying drug authenticity. It also improves efficiency in detecting anomalies and responding to recalls, minimizing health risks associated with counterfeit drugs. Additionally, blockchain integration can help in regulatory reporting and prevent illegal distribution channels. The implications of using blockchain for fake product detection in medicine are significant, promising improved patient safety, greater trust in pharmaceutical supply chains, and enhanced regulatory oversight. However, challenges such as high implementation costs and the need for widespread industry collaboration remain.